Other Viruses Citation List: January 18 - January 31, 2013
Hepatitis C Virus
1. Discovery of Hepatitis C Virus NS3 Helicase Inhibitors by a Multiplexed, High-throughput Helicase Activity Assay Based on Graphene oxide. Jang, H., S.R. Ryoo, Y.K. Kim, S. Yoon, H. Kim, S.W. Han, B.S. Choi, D.E. Kim, and D.H. Min. Angewandte Chemie, 2013. [Epub ahead of print]; PMID[23355441].
[PubMed] OV_0118-013113.
2. Psammaplin A Inhibits Hepatitis C Virus NS3 Helicase. Salam, K.A., A. Furuta, N. Noda, S. Tsuneda, Y. Sekiguchi, A. Yamashita, K. Moriishi, M. Nakakoshi, M. Tsubuki, H. Tani, J. Tanaka, and N. Akimitsu. Journal of Natural Medicines, 2013. [Epub ahead of print]; PMID[23359228].
[PubMed] OV_0118-013113.
3. The Antimalarial Ferroquine is an Inhibitor of Hepatitis C Virus. Vausselin, T., N. Calland, S. Belouzard, V. Descamps, F. Douam, F. Helle, C. Francois, D. Lavillette, G. Duverlie, A. Wahid, L. Feneant, L. Cocquerel, Y. Guerardel, C. Wychowski, C. Biot, and J. Dubuisson. Hepatology, 2013. [Epub ahead of print]; PMID[23348596].
[PubMed] OV_0118-013113.
Hepatitis B Virus
4. The Hepatitis B Virus Ribonuclease H is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes. Tavis, J.E., X. Cheng, Y. Hu, M. Totten, F. Cao, E. Michailidis, R. Aurora, M.J. Meyers, E.J. Jacobsen, M.A. Parniak, and S.G. Sarafianos. PLoS Pathogens, 2013. 9(1): p. e1003125. PMID[23349632].
[PubMed]. HIV_0118-013113.
HSV-1
5. Activity and Mechanism of Action of HDVD, a Novel Pyrimidine Nucleoside Derivative with High Selectivity and Potency against Gammaherpesviruses. Coen, N., U. Singh, V. Vuyyuru, J.J. Van den Oord, J. Balzarini, S. Duraffour, R. Snoeck, Y.C. Cheng, C.K. Chu, and G. Andrei. Journal of Virology, 2013. [Epub ahead of print]; PMID[23345517].
[PubMed] OV_0118-013113.
6. Broad-spectrum Virucidal Activity of (NVC-422) N,N-Dichloro-2,2-dimethyltaurine against Viral Ocular Pathogens in Vitro. Jekle, A., S. Abdul Rani, C. Celeri, M. Zuck, P. Xu, L. Wang, K. Najafi, M. Anderson, D. Stroman, and D. Debabov. Investigative Ophthalmology & Visual Science, 2013. [Epub ahead of print]; PMID[23341010].
[PubMed] OV_0118-013113.
7. A Cationic Peptide, TAT-Cd0, Inhibits Herpes Simplex Virus Type 1 Ocular Infection in Vivo. Jose, G.G., I.V. Larsen, J. Gauger, E. Carballo, R. Stern, R. Brummel, and C.R. Brandt. Investigative Ophthalmology & Visual Science, 2013. [Epub ahead of print]. PMID[23341013].
[PubMed]. HIV_0118-013113.
8. Efficacy of Herpes Virus Helicase-primase Inhibitor, ASP2151, for Treating Herpes Simplex Keratitis in Mouse Model. Sasaki, S.I., D. Miyazaki, T. Haruki, Y. Yamamoto, M. Kandori, K. Yakura, H. Suzuki, and Y. Inoue. The British Journal of Ophthalmology, 2013. [Epub ahead of print]; PMID[23361434].
[PubMed] OV_0118-013113.
Citations from the ISI Web of Knowledge Listings for O.V.
9. Protein Kinase Inhibitors That Inhibit Induction of Lytic Program and Replication of Epstein-Barr Virus. Goswami, R., S. Gershburg, A. Satorius, and E. Gershburg. Antiviral Research, 2012. 96(3): p. 296-304; ISI[000312518100004].
[WOS] OV_0118-013113.
10. Filibuvir. RNA-directed RNA Polymerase (NS5B) Inhibitor, Treatment of Hepatitis C Virus Infection. Kapelusznik, L., E.L. Heil, Z. Temesgen, and R. Talwani. Drugs of the Future, 2012. 37(11): p. 767-775; ISI[000312573700002].
[WOS] OV_0118-013113.